Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AZD4625 |
Trade Name | |
Synonyms | AZD 4625|AZD-4625 |
Drug Descriptions |
AZD4625 selectively inhibits KRAS G12C, potentially leading to decreased tumor cell proliferation and tumor growth (PMID: 35930755). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Afatinib + AZD4625 | AZD4625 Afatinib | 0 | 0 |
AZD4625 | AZD4625 | 0 | 0 |
AZD4625 + Cetuximab | AZD4625 Cetuximab | 0 | 0 |
AZD4625 + Gefitinib | AZD4625 Gefitinib | 0 | 0 |
AZD4625 + RMC-4550 | AZD4625 RMC-4550 | 0 | 0 |
AZD4625 + SHP099 | AZD4625 SHP099 | 0 | 0 |